Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1987-5-11
|
pubmed:abstractText |
We have previously demonstrated that monoclonal anti-I-A/E antibodies inhibit B-cell responses to lipopolysaccharide (LPS). In the present report, the inhibitory effects were shown to be carried out directly on B cells, and to be totally independent of the LPS concentration used, thereby showing that antibodies do not mediate their effect through blocking of accessory cells or steric hindrance of LPS-receptors. Of the three different phases in B-cell activation/induction, proliferation, and maturation, induction was shown to be the most sensitive to inhibition by anti-I-A/E antibodies. Thus, kinetic studies showed that anti-I-A/E antibodies are only inhibitory for the first 16 h of LPS activation, after which B cells can no longer be inhibited by these antibodies. Class II MHC molecules appear, therefore, to be part of a membrane molecular complex which regulates delivery of activation signals to resting B cells. Since it was also shown that this time period corresponds approximately to the time required for B cells to express functional reactivity to growth factors, we suggest that anti-I-A/E antibodies act on resting B lymphocytes to inhibit mitogen-dependent induction of growth receptor expression.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Anti-Idiotypic,
http://linkedlifedata.com/resource/pubmed/chemical/Histocompatibility Antigens Class II,
http://linkedlifedata.com/resource/pubmed/chemical/I-E-antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Lipopolysaccharides
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0300-9475
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
225-34
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:3494300-Animals,
pubmed-meshheading:3494300-Antibodies, Anti-Idiotypic,
pubmed-meshheading:3494300-B-Lymphocytes,
pubmed-meshheading:3494300-Binding, Competitive,
pubmed-meshheading:3494300-Cells, Cultured,
pubmed-meshheading:3494300-Dose-Response Relationship, Immunologic,
pubmed-meshheading:3494300-Histocompatibility Antigens Class II,
pubmed-meshheading:3494300-Lipopolysaccharides,
pubmed-meshheading:3494300-Lymphocyte Activation,
pubmed-meshheading:3494300-Mice,
pubmed-meshheading:3494300-Mice, Inbred Strains,
pubmed-meshheading:3494300-Spleen,
pubmed-meshheading:3494300-Time Factors
|
pubmed:year |
1987
|
pubmed:articleTitle |
The role of I-A/E molecules in B-lymphocyte activation. II. Mechanism of inhibition of the responses to lipopolysaccharide by anti-I-A/E antibodies.
|
pubmed:publicationType |
Journal Article
|